PMC:7274968 / 3131-3341 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":159,"end":167},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma83375"}],"text":"The use of a neoadjuvant treatment up to an expected resolution of the peak of the pandemic was recommended by the 82% of the centers (18/22) if a concomitant androgen deprivation treatment (ADT) was indicated."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T31","span":{"begin":11,"end":12},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T32","span":{"begin":135,"end":137},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T33","span":{"begin":138,"end":140},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T34","span":{"begin":145,"end":146},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"The use of a neoadjuvant treatment up to an expected resolution of the peak of the pandemic was recommended by the 82% of the centers (18/22) if a concomitant androgen deprivation treatment (ADT) was indicated."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":159,"end":167},"obj":"Chemical"},{"id":"T3","span":{"begin":191,"end":194},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50113"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_40799"}],"text":"The use of a neoadjuvant treatment up to an expected resolution of the peak of the pandemic was recommended by the 82% of the centers (18/22) if a concomitant androgen deprivation treatment (ADT) was indicated."}

{"project":"LitCovid-sentences","denotations":[{"id":"T28","span":{"begin":0,"end":210},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The use of a neoadjuvant treatment up to an expected resolution of the peak of the pandemic was recommended by the 82% of the centers (18/22) if a concomitant androgen deprivation treatment (ADT) was indicated."}